Meningococcal Vaccines Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Meningococcal Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 17.6% during the forecast period.

    This report presents the market size and development trends by detailing the Meningococcal Vaccines market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Meningococcal Vaccines market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Meningococcal Vaccines industry and will help you to build a panoramic view of the industrial development.

    Meningococcal Vaccines Market, By Type:

    • Menactra

    • Menomune

    Meningococcal Vaccines Market, By Application:

    • Pneumonia

    • Meningitis

    • Bacteremia

    • Others (Arthritis, Conjunctivitis, Urethritis)

    Some of the leading players are as follows:

    • JN-International Medical

    • Pfizer

    • GlaxoSmithKline

    • Baxter International

    • Novartis International

    • Sanofi

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Meningococcal Vaccines Market

    • 1.3 Market Segment by Type

      • 1.3.1 Menactra

      • 1.3.2 Menomune

    • 1.4 Market Segment by Application

      • 1.4.1 Pneumonia

      • 1.4.2 Meningitis

      • 1.4.3 Bacteremia

      • 1.4.4 Others (Arthritis, Conjunctivitis, Urethritis)

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Meningococcal Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Meningococcal Vaccines by Major Types

      • 3.4.1 Menactra

      • 3.4.2 Menomune

    4 Segmentation of Meningococcal Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Meningococcal Vaccines by Major End-Users

      • 4.4.1 Pneumonia

      • 4.4.2 Meningitis

      • 4.4.3 Bacteremia

      • 4.4.4 Others (Arthritis, Conjunctivitis, Urethritis)

    5 Market Analysis by Major Regions

    • 5.1 Global Meningococcal Vaccines Production Analysis by Top Regions

    • 5.2 Global Meningococcal Vaccines Consumption Analysis by Top Regions

    • 5.3 Global Meningococcal Vaccines Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    6 Product Circulation of Meningococcal Vaccines Market among Top Countries

    • 6.1 Top 5 Export Countries in Meningococcal Vaccines Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Meningococcal Vaccines Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Meningococcal Vaccines Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Meningococcal Vaccines Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Meningococcal Vaccines Landscape Analysis

    • 7.1 North America Meningococcal Vaccines Landscape Analysis by Top Countries

      • 7.1.1 United States Meningococcal Vaccines Market Volume and Growth Rate

      • 7.1.2 Canada Meningococcal Vaccines Market Volume and Growth Rate

      • 7.1.3 Mexico Meningococcal Vaccines Market Volume and Growth Rate

    8. Europe Meningococcal Vaccines Landscape Analysis

    • 8.1 Europe Meningococcal Vaccines Landscape Analysis by Major Types

    • 8.2 Europe Meningococcal Vaccines Landscape Analysis by Major End-Users

    • 8.3 Europe Meningococcal Vaccines Landscape Analysis by Top Countries

      • 8.3.1 Germany Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.2 UK Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.3 France Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.4 Italy Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.5 Spain Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.6 Belgium Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.7 Poland Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.8 Russia Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.9 Turkey Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.10 Netherlands Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.11 Portugal Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.12 Denmark Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.13 Finland Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.14 Iceland Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.15 Norway Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.16 Sweden Meningococcal Vaccines Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Meningococcal Vaccines Landscape Analysis

    • 9.1 Asia Pacific Meningococcal Vaccines Landscape Analysis by Top Countries

      • 9.1.1 China Meningococcal Vaccines Market Volume and Growth Rate

      • 9.1.2 Japan Meningococcal Vaccines Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Meningococcal Vaccines Market Volume and Growth Rate

      • 9.1.4 India Meningococcal Vaccines Market Volume and Growth Rate

      • 9.1.5 ASEAN Meningococcal Vaccines Market Volume and Growth Rate

      • 9.1.6 South Korea Meningococcal Vaccines Market Volume and Growth Rate

    10 LAMEA Meningococcal Vaccines Landscape Analysis

    • 10.1 LAMEA Meningococcal Vaccines Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Meningococcal Vaccines Market Volume and Growth Rate

      • 10.1.2 Brazil Meningococcal Vaccines Market Volume and Growth Rate

      • 10.1.3 North Africa Meningococcal Vaccines Market Volume and Growth Rate

      • 10.1.4 South Africa Meningococcal Vaccines Market Volume and Growth Rate

      • 10.1.5 Argentina Meningococcal Vaccines Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 JN-International Medical

      • 11.1.1 JN-International Medical Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Pfizer

      • 11.2.1 Pfizer Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 GlaxoSmithKline

      • 11.3.1 GlaxoSmithKline Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Baxter International

      • 11.4.1 Baxter International Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Novartis International

      • 11.5.1 Novartis International Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Sanofi

      • 11.6.1 Sanofi Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 104 Figures and 145 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of Menactra

    • Figure Market Size and Growth Rate of Menomune

    • Figure Market Size and Growth Rate of Pneumonia

    • Figure Market Size and Growth Rate of Meningitis

    • Figure Market Size and Growth Rate of Bacteremia

    • Figure Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis)

    • Figure North America Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure United States Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure UK Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure France Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure China Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure India Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Meningococcal Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Meningococcal Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Meningococcal Vaccines by Different Types from 2014 to 2026

    • Table Consumption Share of Meningococcal Vaccines by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Menactra

    • Figure Market Size and Growth Rate of Menomune

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Meningococcal Vaccines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Meningococcal Vaccines by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Pneumonia

    • Figure Market Size and Growth Rate of Meningitis

    • Figure Market Size and Growth Rate of Bacteremia

    • Figure Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis)

    • Table Global Meningococcal Vaccines Production by Major Regions

    • Table Global Meningococcal Vaccines Production Share by Major Regions

    • Table Global Meningococcal Vaccines Consumption by Major Regions

    • Table Global Meningococcal Vaccines Consumption Share by Major Regions

    • Table North America Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Europe Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table LAMEA Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Meningococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table North America Meningococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Meningococcal Vaccines Consumption Share by Major Countries in 2014

    • Figure North America Meningococcal Vaccines Consumption Share by Major Countries in 2018

    • Figure North America Meningococcal Vaccines Consumption Share by Major Countries in 2026

    • Figure United States Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Europe Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Europe Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Europe Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Europe Meningococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Europe Meningococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure France Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Meningococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Meningococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure China Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure India Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Meningococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Meningococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of JN-International Medical

    • Figure Sales and Growth Rate Analysis of JN-International Medical

    • Figure Revenue and Market Share Analysis of JN-International Medical

    • Table Product and Service Introduction of JN-International Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter International

    • Figure Sales and Growth Rate Analysis of Baxter International

    • Figure Revenue and Market Share Analysis of Baxter International

    • Table Product and Service Introduction of Baxter International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis International

    • Figure Sales and Growth Rate Analysis of Novartis International

    • Figure Revenue and Market Share Analysis of Novartis International

    • Table Product and Service Introduction of Novartis International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.